This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2023) scheduled during April 24-26, 2023 in Orlando, Florida, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at precision-medicine@magnusconference.com or call + 1 (702) 988 2320.
All health care decisions and quality measures are driven by an individual's specific health needs and desired health outcomes in patient-centered care. Patients and their health-care professionals are partners, and providers serve patients not only clinically, but also emotionally, mentally, spiritually, socially, and financially. In order to build and administer a unique and comprehensive treatment plan, patient- and family-centered care fosters active cooperation and shared decision-making among patients, families, and providers. The concept of patient-centered care is applied to the treatments and therapies provided by professionals. Not only are treatment plans personalized to the individual, but drugs are also frequently customized. In many disease conditions — particularly cancer — a patient's genetics, metabolism, biomarkers, immune system, and other "signatures" can now be used to develop personalized drugs and therapies, and also companion diagnostics that assist clinicians better anticipate the best drug for each patient.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Leveraging blockchain technology, edge computing and federated learning to enhance outcomes in precision medicine
Ingrid Vasiliu Feltes, MEDNAX, United States
Title : The new horizons in the patient- centered care for understanding of the reasons of its health problems – Psychosynthesis approach
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Hegazy theory for interpretation of human parthenogenesis: A new hypothesis
Abdelmonem Awad Hegazy, Zagazig University, Egypt
Title : Precision Oncology and Personalised Medicine: Innovative Technology for the Treatment of Colorectal Cancer
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : The role of CD44v6 as a new immunotherapy target for urothelial cancer
Iris Adriana Maria Lodewijk, Institute of Biomedical Research, Spain